A galanin receptor subtype 1 specific agonist

International Journal of Peptide Research and Therapeutics

Volumn 11, Issue 1, 2005, Pages 17-27

  Lundström, Linda ^a   Sollenberg, Ulla ^a   Brewer, Ariel ^b   Kouya, Poli Francois ^c   Zheng, Kang ^c   Xu, Xiao Jun ^c   Sheng, Xia ^c   Robinson, John K ^b   Wiesenfeld Hallin, Zsuzsanna ^c   Xu, Zhi Qing ^c   Hökfelt, Tomas ^c   Bartfai, Tamas ^d   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b STONY BROOK UNIVERSITY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

cAMP production; Chimeric peptide; Feeding behavior; Galanin; Galanin receptor; Inositol phosphate production; Locus coeruleus; Nociception; Receptor internalization; Receptor specificity

Indexed keywords

CALCIUM ION; CHIMERIC PROTEIN; CYCLIC AMP; FORSKOLIN; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; INOSITOL PHOSPHATE; LIGAND; M 35; M 617; MAGNESIUM ION; OPIATE AGONIST; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INHIBITION; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HUMAN CELL; INTERNALIZATION; LOCUS CERULEUS; MALE; NERVE EXCITABILITY; NONHUMAN; POSTSYNAPTIC INHIBITION; RAT; SIGNAL TRANSDUCTION; SPINAL REFLEX;

ANIMALIA;

EID: 20444383376     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-004-1717-z     Document Type: Article

References (36)

1. Abramov, U., Florén, A., Echevarria, D. J., Brewer, A., Manuzon, H., Robinson, J. K., Bartfai, T., Vasar, E. and Langel, Ü.: 2004, Neuropeptides. 38, 55-61.
2. Bartfai, T., Langel, Ü., Bedecs, K., Andell, S., Land, T., Gregersen, S., Ahrén, B., Girotti, P., ConsoloCoring, S. and Corwin, R.: 1993, Proc. Natl. Acad. Sci. USA. 90, 11287-11291.
3. Borowsky, B., Walker, M. W., Huang, L.Y., Jones, K. A., Smith, K. E., Bard, J., Branchek, T. A. and Gerald, C.: 1998, Peptides. 19, 1771-1781.
4. Branchek, T. A., Smith, K. E., Gerald, C. and Walker, M. W.: 2000, Trends Pharmacol. Sci. 21, 109-117.
5. Chan-Palay, V.: 1988, Brain Res. Bull. 21, 465-472.
6. Ch'ng, J. L., Christofides, N. D., Anand, P., Gibson, S. J., Allen, Y. S., Su, H. C., Tatemoto, K., Morrison, J. F., Polak, J. M. and Bloom, S. R.: 1985, Neuroscience. 16, 343-354.
7. Crawley, J. N.: 1999, Neuropeptides. 33, 369-375.
8. Crawley, J. N., Robinson, J. K., Langel, Ü. and Bartfai, T.: 1993, Brain Res. 600, 268-272.
9. Fathi, Z., Cunningham, A. M., Iben, L. G., Battaglino, P. B., Ward, S. A., Nichol, K. A., Pine, K. A., Wang, J., Goldstein, M. E., Iismaa, T. P. and Zimanyi, I. A.: 1997, Brain Res. Mol. Brain Res. 51,49-59.
10. Florén, A., Land, T. and Langel, Ü.: 2000, Neuropeptides. 34, 331-337.
11. Habert-Ortoli, E., Amiranoff, B., Loquet, I., Laburthe, M. and Mayaux, J. F.: 1994, Proc. Natl Acad. Sci. USA. 91, 9780-9783.
12. Heuillet, E., Bouaiche, Z., Menager, J., Dugay, P., Munoz, N., Dubois, H., Amiranoff, B., Crespo, A., Lavayre, J. and Blanchard, J. C.: 1994, Eur. J. Pharmacol. 269, 139-147.
13. Ignatov, A., Hermans-Borgmeyer, I. and Schaller, H. C.: 2004, Neuropharmacology. 46, 1114-1120.
14. Kask, K., Berthold, M., Bourne, J., Andell, S., Langel, Ü. and Bartfai, T.: 1995, Regul. Peptides. 59, 341-348.
15. Kyrkouli, S. E., Stanley, B. G., Seirafi, R. D. and Leibowitz, S. F.: 1990, Peptides. 11,995-1001.
16. Liu, H. X. and Hökfelt, T.: 2002, Trends Pharmacol. Sci. 23, 468-474.
17. Liu, H. X., Brumovsky, P., Schmidt, R., Brown, W., Payza, K., Hodzic, L., Pou, C., Godbout, C. and Hökfelt, T.: 2001, Proc. Natl. Acad. Sci. USA. 98, 9960-9964.
18. Ma, X., Tong, Y. G., Schmidt, R., Brown, W., Payza, K., Hodzic, L., Pou, C., Godbout, C., Hökfelt, T. and Xu, Z. Q.: 2001, Brain Res. 919, 169-174.
19. Mazarati, A., Langel, Ü. and Bartfai, T.: 2001, Neuroscientist. 7, 506-517.
20. Melander, T., Hökfelt, T., Rökaeus, A., Cuello, A. C., Oertel, W. H., Verhofstad, A. and Goldstein, M.: 1986, J. Neurosci. 6, 3640-3654.
21. Ottlecz, A., Snyder, G. D. and McCann, S. M.: 1988, Proc. Natl. Acad. Sci. USA. 85, 9861-9865.
22. Sjöholm, A. and Efendic, S.: 2001, Exp. Clin. Endocrinol. Diabetes. 109(Suppl 2), S109-121.
23. Skofitsch, G. and Jacobowitz, D. M.: 1985, Brain Res. Bull. 15, 191-195.
24. Skofitsch, G., Jacobowitz, D. M., Amann, R. and Lembeck, F.: 1989, Neuroendocrinology. 49, 419-427.
25. Smith, K. E., Forray, C., Walker, M. W., Jones, K. A., Tamm, J. A., Bard, J., Branchek, T. A., Linemeyer, D. L. and Gerald, C.: 1997, J. Biol. Chem. 272, 24612-24616.
26. Smith, K. E., Walker, M. W., Artymyshyn, R., Bard, J., Borowsky, B., Tamm, J. A., Yao, W. J., Vaysse, P. J., Branchek, T. A., Gerald, C. and Jones, K. A.: 1998, J. Biol. Chem. 273, 23321-23326.
27. Tatemoto, K., Rökaeus, A., Jørnvall, H., McDonald, T. J. and Mutt, V.: 1983, FEBS Lett. 164, 124-128.
28. Valkna, A., Juréus, A., Karelson, E., Zilmer, M., Bartfai, T. and Langel, Ü.: 1995, Neurosci. Lett. 187, 75-78.
29. Wang, S., Hashemi, T., He, C., Strader, C. and Bayne, M.: 1997a, Mol. Pharmacol. 52, 337-343.
30. Wang, S., He, C., Hashemi, T. and Bayne, M.: 1997b, J. Biol. Chem. 272, 31949-31952.
31. Wang, S., Hashemi, T., Fried, S., Clemmons, A. L. and Hawes, B. E.: 1998, Biochemistry. 37, 6711-6717.
32. Wiesenfeld-Hallin, Z., Villar, M. J. and Hökfelt, T.: 1989, Brain Res. 486, 205-213.
33. Wrenn, C. C. and Crawley, J. N.: 2001, Prog. Neuropsychopharmacol. Biol. Psychiatry. 25, 283-299.
34. Xu, X. J., Wiesenfeld-Hallin, Z., Villar, M. J., Fahrenkrug, J. and Hökfelt, T.: 1990, Eur. J. Neurosci. 2, 733-743.
35. Xu, X. J., Wiesenfeld-Hallin, Z. and Hökfelt, T.: 1991, Brain Res.. 541, 350-353.
36. Xu, X. J., Hökfelt, T., Bartfai, T. and Wiesenfeld-Hallin, Z.: 2000, Neuropeptides. 34, 137-147.